Event Date: October 9, 2023

Southern California Pipetrades District Council 16 Aim to Cure Mesothelioma

This year's event returned to the Moore N Moore Sporting Clay facility in San Fernando, CA where we had the largest turnout the event has ever seen, with over 155 participants! Representing the Foundation at the event were Executive Director, Elizabeth Ann Paul, Founding Board Member, Jerry Neil Paul, Chairman of the Medical Advisory Committee, Dr. Parkash Gill, and Assistant Executive Director, Shane Rucker.

read more...


Event Date: July 10, 2023

Southern California Pipetrades District Council 16 Annual Golf Invitational

This year's Southern California Pipetrades District Council 16 Annual Golf Invitational was held at the beautiful Alta Vista Country Club in Placentia, CA, and marked the event's 20th anniversary. A record number of golfers and supporters joined us to raise over $155,000 for mesothelioma cancer research! Representing the Mesothelioma Research Foundation of America were, Executive Director Elizabeth Ann Paul, Chairman of the Medical Advisory Committee, Dr. Parkash Gill and Assistant Executive Director Shane Rucker.

read more...


Event Date: June 26, 2023

Roger Hamilton Memorial Golf Invitational

On June 26, 2023, the Roger Hamilton Memorial Golf Invitational marked our 21st annual presentation at the Chardonnay Golf Course in Napa, California. The Invitational generated ample funds for mesothelioma cancer research and clinical trials that we hope will lead to better treatment options. We saw a fantastic turnout of over 140 golfers, with the event generating over $95,000 in total! As always, 100% of the funds raised will go toward supporting Dr. Parkash Gill's research at the USC Norris Comprehensive Cancer Center.

read more...


Event Date: June 9, 2023

California State Pipe Trades Aim to Cure Mesothelioma - Birds Landing, California

The 2023 California State Pipe Trades Aim to Cure Mesothelioma clay shoot, hosted by Foundation Board Member and Retired International Pipe Trades Representative, Jim Kellogg, kicked off this year's fundraising efforts with monumental results. Together, with supporters of the California State Pipe Trades, we netted approximately $45,000.00 to contribute to mesothelioma research! We had a gigantic turnout of over 175 shooters and supporters, all converging on the Birds Landing Hunting Preserve and Sporting Clay Facility. Representing the Foundation at the event were Board Members Jim Kellogg and Jerry Neil Paul, as well as Assistant Executive Director Shane Rucker.

read more...


Bring your Mesothelioma questions to us: click HERE

DONATIONS for cancer cure

100 percent of all proceeds received are going to the USC Norris Comprehensive Cancer Medical Center in Los Angeles to support the FDA clinical trials. These trials include Veglin, a mesothelioma cancer treatment. Veglin manipulates the blood vessels to starve a malignant tumor while alleviating fluid build up in the lungs

Support the hope in this research and click HERE


Patient Assistance Programs are offered by many pharmaceutical manufacturers to help pay for medications. These offers are sometimes called Indigent Drug Programs. Use our link just following, and learn whether a specific drug might be available at reduced cost or for free.

Drug Assistance Programs: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of the pharmaceutical company that makes the drug you are using


Find the lastest Mesothelioma clinical trials: click HERE

To ask your Cancer questions: click HERE

Help this Foundation and click HERE


Cancer imposes heavy economic burdens on a cancer patients and family members alike. Resources are available for individuals who do not have health insurance or who need financial assistance to cover health care costs. Our listing will help you find Government agencies, private organizations, and programs that are designed to provide assistance for a cancer patient and their family.

Financial help for cancer patients: click HERE

At the Mesothelioma Research Foundation of America, you can call toll free (800) 909-Meso (6376) to talk with one of our Cancer Information Specialists who will gladly look up the phone numbers or the web site of organizations that provide financial assistance.

Bring us your Mesothelioma cancer questions: click HERE

Help grow the Foundation and cancer-cure research: click HERE

Pause
Resume

THE FOUNDATION

The Mesothelioma Research Foundation of America has a mission: to fund research that will lead to the quickest cure for mesothelioma. Mesothelioma, a cancer of the lining of the lungs caused by asbestos exposure, had very few treatment options back in the year 2001. Since then the Foundation has funded the opening of the Mesothelioma Laboratory under the supervision of Dr. Gill at the USC/Norris Comprehensive Cancer Center in Los Angeles. In the process, Dr. Gill (a board certified oncologist and hematologist) had received FDA approval from the U.S. Government to do Phase I Clinical Trials on a new mesothelioma treatment drug called Veglin, whose research was 100% funded by the Foundation. It proved successful in Phase I and Phase II of the clinical trials for Veglin began July 30th, 2004. And since 2021 when Phase 2 Clinical Trials utilizing EphB-4 with Mercks PD-1 were approved, we are all very excited at the possibilities of a more effective treatment over what presently was available for mesothelioma victims.

James W. Kellogg, Jerry Neil Paul, Elizabeth Paul and Dr. Parkash Gill, M.D.
The Foundation Board Members from the left are: James W. Kellogg, Jerry Neil Paul, and Elizabeth Ann Paul. These are respectively the United Association International Representative, Founding Director, Executive Director and Dr. Parkash Gill, M.D. as Chairman of the Medical Advisory Committee.

Also, the Mesothelioma Research Foundation of America's mission includes supporting cancer research and (or) clinical trials that include other cancers as long as the published research and or governing publishing authors, University, National Cancer Institute, or FDA plan to include Mesothelioma as one of the targeted cancers. The ultimate goal is to promote and make available more innovative treatment options as we attempt to help mesothelioma victims.

Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center had previously announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Clinical Trials and is available to qualifying mesothelioma patients. We are continuously searching for better and better clinical trial results until this battle is won. The current Clinical Trial of EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options, as well as to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting because Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs like Alimta, Cisplatin and Carboplatin. Dr. Gill has requested for the National Cancer Institute approval to support EphB4 in clinical trials in conjunction with active immunotherapy experimental treatment PD-1 antibody.

Since 2021, Dr. Gill has gotten FDA approval for Phase 2 Clinical Trials utilizing EphB-4 with Mercks PD-1, both immunotherapy drugs tied in with genetic testing of a cancer victim's DNA to maximize it's benefits.


2023-24 events

Event Date: October 9, 2023

Southern California Pipetrades District Council 16 Aim to Cure Mesothelioma

This year's event returned to the Moore N Moore Sporting Clay facility in San Fernando, CA where we had the largest turnout the event has ever seen, with over 155 participants! Representing the Foundation at the event were Executive Director, Elizabeth Ann Paul, Founding Board Member, Jerry Neil Paul, Chairman of the Medical Advisory Committee, Dr. Parkash Gill, and Assistant Executive Director, Shane Rucker.

read more...


Event Date: July 10, 2023

Southern California Pipetrades District Council 16 Annual Golf Invitational

This year's Southern California Pipetrades District Council 16 Annual Golf Invitational was held at the beautiful Alta Vista Country Club in Placentia, CA, and marked the event's 20th anniversary. A record number of golfers and supporters joined us to raise over $155,000 for mesothelioma cancer research! Representing the Mesothelioma Research Foundation of America were, Executive Director Elizabeth Ann Paul, Chairman of the Medical Advisory Committee, Dr. Parkash Gill and Assistant Executive Director Shane Rucker.

read more...


Event Date: June 26, 2023

Roger Hamilton Memorial Golf Invitational

On June 26, 2023, the Roger Hamilton Memorial Golf Invitational marked our 21st annual presentation at the Chardonnay Golf Course in Napa, California. The Invitational generated ample funds for mesothelioma cancer research and clinical trials that we hope will lead to better treatment options. We saw a fantastic turnout of over 140 golfers, with the event generating over $95,000 in total! As always, 100% of the funds raised will go toward supporting Dr. Parkash Gill's research at the USC Norris Comprehensive Cancer Center.

read more...


Event Date: June 9, 2023

California State Pipe Trades Aim to Cure Mesothelioma - Birds Landing, California

The 2023 California State Pipe Trades Aim to Cure Mesothelioma clay shoot, hosted by Foundation Board Member and Retired International Pipe Trades Representative, Jim Kellogg, kicked off this year's fundraising efforts with monumental results. Together, with supporters of the California State Pipe Trades, we netted approximately $45,000.00 to contribute to mesothelioma research! We had a gigantic turnout of over 175 shooters and supporters, all converging on the Birds Landing Hunting Preserve and Sporting Clay Facility. Representing the Foundation at the event were Board Members Jim Kellogg and Jerry Neil Paul, as well as Assistant Executive Director Shane Rucker.

read more...


Clinical Trials Status

Dr. Parkish Gill seeks  cure for mesothelioma cancer
Dr. Parkash Gill

 

Dr. Parkash Gill of the USC Norris Comprehensive Cancer Center has announced that the new cancer fighting drug EPH-B4 has been submitted to the FDA for Phase I Clinical Trials and is available to qualifying mesothelioma patients. In the initial Phase I Trial EPH-B4 is available to newly diagnosed patients who have not undergone any conventional treatment options and to those patients who have exhausted all other treatment options such as surgery and chemotherapy. This is truly exciting as Dr. Gill has reported that EPH-B4 has shown great promise as a solo treatment or in conjunction with other drugs as Alimta, Cisplatin and Carboplatin.


Please use our FaceBook link to obtain your FREE copy of our eBook that teaches:

10 Easy Steps On How To Find And Choose A Clinical Trial For Mesothelioma And How To Prepare For It!

Ask us questions about your specific mesothelioma issues here: Ask Questions

In addition to the eBook found at our Facebook fan page, also learn more about clinical trials from these links:


There have been significant improvements creating new options for patients with Mesothelioma lung cancer. This video presents the new options for a patient to be aware of and consider. This news release video, created by Med Page Today, is about Oncology and Lung Cancer has been shared on YouTube by the Mesothelioma Research Foundation of America.

 

 


Lyons Foundation Chooses MesoRFA

The Mesothelioma Research Foundation of America is the proud recipient of a grant from the John S. Lyons Memorial Foundation, charitable branch of the San Diego Building Trades Councel, to help support clinical studies of Dr. Parkash Gill's protein known as EPH B4 as a mesothelioma cancer treatment option.

John S. Lyons Memorial Foundation

Read More...

Top of Page